Three Dimensional Power Doppler evaluation of human endometrium after administration of oxytocine receptor antagonist (OTRa) in an IVF program
- PMID: 21822907
- DOI: 10.1007/s00404-011-2019-2
Three Dimensional Power Doppler evaluation of human endometrium after administration of oxytocine receptor antagonist (OTRa) in an IVF program
Abstract
Purpose: To compare endometrial and subendometrial morphological changes and vascularity as measured by 3D Power Doppler sonography, based on a specific scoring system between women subjected or not to oxytocine receptor antagonist (OTRa) during IVF cycles.
Methods: Twenty-six women were divided into groups according to OTRa (Atosiban tractocide) administration. The first group (control n = 13 women) was examined with 3D Power Doppler 3 days after embryo transfer. The second group (n = 13 women) was administered 7.5 mg intravenous tractocide 2 days after embryo transfer and a 3D Power Doppler was performed after a day.
Results: The control group presented the following ultrasonographic characteristics: (a) echogenic endometrium in all cases, (b) endometrial thickness >7 mm in all cases (84.6%), (c) endometrial volume >2.31 cm(3) in 5 cases (38.5%), (d) abnormal sub-endometrial halo in 3 cases (23.1%), (e) endometrial blood flow in 6 cases (46.2%) and (f) complex vessel's architecture in 2 cases (15.4%). In women who underwent OTRa administration were observed: (a) echogenic endometrium in 1 case (7.7%), triple line endometrium in 12 cases (92.3%), (b) endometrial thickness >7 mm in all cases, (c) endometrial volume >2.31 cm(3) in 11 cases (84.6%), (d) abnormal sub-endometrial halo in 3 cases (23.1%), (e) endometrial blood flow in 11 cases (84.6%) and (f) complex vessel's architecture in 6 cases (46.2%).
Conclusions: Women who have taken OTRa presented an endometrium with characteristics more predictive of implantation.
Similar articles
-
Detection of endometrial and subendometrial vasculature on the day of embryo transfer and prediction of pregnancy during fresh in vitro fertilization cycles.Taiwan J Obstet Gynecol. 2014 Sep;53(3):360-5. doi: 10.1016/j.tjog.2013.05.007. Taiwan J Obstet Gynecol. 2014. PMID: 25286791
-
The role of endometrial and subendometrial vascularity measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during frozen-thawed embryo transfer cycles.Hum Reprod. 2006 Jun;21(6):1612-7. doi: 10.1093/humrep/dei502. Epub 2006 Jan 31. Hum Reprod. 2006. PMID: 16449309
-
Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?Fertil Steril. 2008 Jan;89(1):111-7. doi: 10.1016/j.fertnstert.2007.02.029. Epub 2007 Jun 6. Fertil Steril. 2008. PMID: 17555754
-
The role of endometrial blood flow measured by three-dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment.Eur J Obstet Gynecol Reprod Biol. 2007 Nov;135(1):8-16. doi: 10.1016/j.ejogrb.2007.06.006. Epub 2007 Jul 20. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 17658677 Review.
-
[Using ultrasound imaging in implantation].Zentralbl Gynakol. 2001 Jun;123(6):340-3. doi: 10.1055/s-2001-16288. Zentralbl Gynakol. 2001. PMID: 11488161 Review. German.
Cited by
-
A Prospective Case-control Trial to Evaluate and Compare the Efficacy and Safety of Atosiban versus Placebo in In vitro Fertilization-embryo Transfer Program.J Hum Reprod Sci. 2018 Apr-Jun;11(2):155-160. doi: 10.4103/jhrs.JHRS_7_17. J Hum Reprod Sci. 2018. PMID: 30158812 Free PMC article.
-
Re-embarking in ART while still breastfeeding: an unresolved question.Arch Gynecol Obstet. 2025 Feb;311(2):555-565. doi: 10.1007/s00404-025-07933-8. Epub 2025 Jan 20. Arch Gynecol Obstet. 2025. PMID: 39828777 Free PMC article. Review.
-
Atosiban application in fresh ET cycle is effective for women undergoing repeated embryo implantation failures, especially for advanced-age obese patients.Sci Rep. 2023 Dec 27;13(1):23044. doi: 10.1038/s41598-023-49773-z. Sci Rep. 2023. PMID: 38155160 Free PMC article.
-
Confirmation of the cardiac safety of nolasiban in a randomised cohort of healthy female volunteers.Sci Rep. 2021 Mar 18;11(1):6404. doi: 10.1038/s41598-021-85650-3. Sci Rep. 2021. PMID: 33739022 Free PMC article.
-
Oxytocin antagonists for assisted reproduction.Cochrane Database Syst Rev. 2021 Sep 1;9(9):CD012375. doi: 10.1002/14651858.CD012375.pub2. Cochrane Database Syst Rev. 2021. PMID: 34467530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources